Freestone Grove Partners LP Portfolio Holdings

Freestone Grove Partners LP

  • $13.4 Trillion
  • Q3 2025

Freestone Grove Partners LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $13.4 Trillion distributed in 678 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vanguard Index Fds S&P 500 ETF with a value of $828B, Ishares Core S&P 500 ETF with a value of $201B, Weyerhaeuser CO with a value of $166B, Cintas Corp with a value of $153B, and Mastec Inc with a value of $144B.

Examining the 13F form we can see an increase of $146B in the current position value, from $13.2T to 13.4T.

Freestone Grove Partners LP is based out at San Francisco, CA

Below you can find more details about Freestone Grove Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $13.4 Trillion
Industrials: $2.14 Trillion
Financial Services: $1.78 Trillion
Technology: $1.63 Trillion
Healthcare: $1.37 Trillion
Consumer Cyclical: $1.26 Trillion
Consumer Defensive: $763 Billion
Energy: $690 Billion
Communication Services: $649 Billion
Other: $1.22 Trillion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$5.65B
$910 Million 0.01% of portfolio
11,599
Q3 2025 New
$719M
$1.08 Billion 0.01% of portfolio
108,874
Q3 2025 New
$11.4B
$1.01 Billion 0.01% of portfolio
2,493
Q3 2025 Reduced 64.02%
$22.7B
$1.52 Billion 0.01% of portfolio
5,064
Q3 2025 New
Waterbridge Infrastructure L
-
$681 Million 0.01% of portfolio
-
Q3 2025 New
$7.87B
$1.69 Billion 0.01% of portfolio
19,862
Q3 2025 New
$2.76B
$874 Million 0.01% of portfolio
5,325
Q3 2025 Reduced 70.24%
$2.33B
$812 Million 0.01% of portfolio
15,451
Q3 2025 Reduced 22.12%
$12.2B
$1.61 Billion 0.01% of portfolio
8,032
Q3 2025 Added 28.2%
$84B
$815 Million 0.01% of portfolio
4,238
Q3 2025 Reduced 23.94%
$15.9B
$1.22 Billion 0.01% of portfolio
4,341
Q3 2025 Reduced 21.14%
$2.91B
$710 Million 0.01% of portfolio
58,043
Q3 2025 Added 40.16%
Rapport Therapeutics Inc
-
$1.34 Billion 0.01% of portfolio
-
Q3 2025 New
$47B
$1.67 Billion 0.01% of portfolio
3,393
Q3 2025 New
$1.57B
$740 Million 0.01% of portfolio
21,154
Q3 2025 New
$3.33B
$1.11 Billion 0.01% of portfolio
21,152
Q3 2025 Added 4.47%
$6.31B
$867 Million 0.01% of portfolio
15,386
Q3 2025 New
$2.69B
$771 Million 0.01% of portfolio
14,463
Q3 2025 New
$5.22B
$1.93 Billion 0.01% of portfolio
21,542
Q3 2025 Added 200.49%
$442M
$1.12 Billion 0.01% of portfolio
28,121
Q3 2025 New
$12.6B
$1.86 Billion 0.01% of portfolio
227,546
Q3 2025 Reduced 37.14%
$6.91B
$1.35 Billion 0.01% of portfolio
48,617
Q3 2025 New
$2.76B
$723 Million 0.01% of portfolio
9,855
Q3 2025 Added 73.47%
$2.39B
$1.88 Billion 0.01% of portfolio
13,983
Q3 2025 Added 5.0%
$3.56B
$671 Million 0.01% of portfolio
7,171
Q3 2025 New
$5.3B
$1.5 Billion 0.01% of portfolio
14,070
Q3 2025 New
$4.89B
$1.11 Billion 0.01% of portfolio
11,145
Q3 2025 New
$21.3B
$1.78 Billion 0.01% of portfolio
9,203
Q3 2025 New
$9.51B
$727 Million 0.01% of portfolio
2,618
Q3 2025 Reduced 4.73%
$2.79B
$1.43 Billion 0.01% of portfolio
29,787
Q3 2025 Reduced 0.58%
$1.75B
$865 Million 0.01% of portfolio
96,377
Q3 2025 Reduced 54.45%
$7.02B
$1.16 Billion 0.01% of portfolio
22,988
Q3 2025 New
$1.14B
$840 Million 0.01% of portfolio
16,244
Q3 2025 Reduced 13.01%
$2.69B
$933 Million 0.01% of portfolio
14,865
Q3 2025 Added 278.34%
$39.2B
$1.14 Billion 0.01% of portfolio
11,861
Q3 2025 Added 9.48%
$3.64B
$741 Million 0.01% of portfolio
14,438
Q3 2025 New
$1.31B
$1.62 Billion 0.01% of portfolio
47,140
Q3 2025 New
$2.16B
$1.13 Billion 0.01% of portfolio
27,793
Q3 2025 Reduced 0.25%
$6.99B
$1.82 Billion 0.01% of portfolio
45,014
Q3 2025 New
$8.25B
$1.39 Billion 0.01% of portfolio
45,649
Q3 2025 New
$4.52B
$1.01 Billion 0.01% of portfolio
12,077
Q3 2025 New
$4.16B
$788 Million 0.01% of portfolio
7,988
Q3 2025 Reduced 14.71%
$18.3B
$959 Million 0.01% of portfolio
19,575
Q3 2025 Reduced 92.37%
$4.87B
$733 Million 0.01% of portfolio
6,092
Q3 2025 Added 132.87%
$14.8B
$1.47 Billion 0.01% of portfolio
30,039
Q3 2025 Reduced 50.43%
$20.9B
$1.29 Billion 0.01% of portfolio
7,231
Q3 2025 Reduced 94.65%
$5.68B
$1.28 Billion 0.01% of portfolio
7,905
Q3 2025 Reduced 55.32%
$3.06B
$672 Million 0.01% of portfolio
11,341
Q3 2025 Added 14.95%
$114B
$788 Million 0.01% of portfolio
3,649
Q3 2025 New

Summary

  • Portfolio
  • No. of Stocks 678
  • Current Value $13.4 Trillion
  • Prior Value $13.2 Trillion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 296 stocks
  • Additional Purchases 171 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 189 stocks
Track This Portfolio

Track Freestone Grove Partners LP Portfolio

Follow Freestone Grove Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Grove Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Grove Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email